Literature DB >> 22578529

The isoflavone puerarin reduces alcohol intake in heavy drinkers: a pilot study.

David M Penetar1, Lindsay H Toto, Stacey L Farmer, David Y-W Lee, Zhongze Ma, Yanze Liu, Scott E Lukas.   

Abstract

BACKGROUND: Isoflavone compounds naturally occurring in the root of the kudzu plant have been used historically to treat alcohol-related problems. A pilot study was conducted to assess the effects of one primary isoflavone--puerarin--for its ability to modify alcohol intake in humans.
METHODS: Ten (10) healthy adult volunteers were administered puerarin (1200 mg daily) in a double-blind, placebo-controlled, crossover design experiment for one week prior to an afternoon drinking session lasting 1.5h. Participants had access to up to six bottles of their preferred brand of beer in addition to juice and water. A time course of drinking, sip volumes, and total amount consumed were recorded.
RESULTS: Participants consumed on average 3.5 (±0.55) beers when treated with placebo and 2.4 (±0.41) beers when treated with puerarin. In contrast to drinking following placebo treatment when 3 participants drank 5 beers and 1 participant drank all 6 beers, none drank 5 or 6 beers when treated with puerarin. Drinking topography also changed. When treated with puerarin, participants decreased sip size, took more sips to finish a beer, and took longer to consume each beer. Additionally, after finishing a beer, latency to opening the next beer was increased.
CONCLUSIONS: This study is the first demonstration that a single isoflavone found in the kudzu root can alter alcohol drinking in humans. These results suggest that alcohol consumption patterns are influenced by puerarin administration and this botanical medication may be a useful adjunct in the treatment of excessive alcohol intake.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22578529      PMCID: PMC3430804          DOI: 10.1016/j.drugalcdep.2012.04.012

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  19 in total

1.  A pilot study exploring the effect of kudzu root on the drinking habits of patients with chronic alcoholism.

Authors:  J Shebek; J P Rindone
Journal:  J Altern Complement Med       Date:  2000-02       Impact factor: 2.579

2.  Alcohol urges in alcohol-dependent drinkers: further validation of the Alcohol Urge Questionnaire in an untreated community clinical population.

Authors:  D Colin Drummond; Thomas S Phillips
Journal:  Addiction       Date:  2002-11       Impact factor: 6.526

3.  Development and initial validation of a measure of drinking urges in abstinent alcoholics.

Authors:  M J Bohn; D D Krahn; B A Staehler
Journal:  Alcohol Clin Exp Res       Date:  1995-06       Impact factor: 3.455

4.  Daidzin and daidzein suppress free-choice ethanol intake by Syrian golden hamsters.

Authors:  W M Keung; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

5.  Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.

Authors:  G Y Gao; D J Li; W M Keung
Journal:  J Med Chem       Date:  2001-09-27       Impact factor: 7.446

6.  Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism.

Authors:  R C Lin; S Guthrie; C Y Xie; K Mai; D Y Lee; L Lumeng; T K Li
Journal:  Alcohol Clin Exp Res       Date:  1996-06       Impact factor: 3.455

7.  Effects of purified puerarin on voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol.

Authors:  Elhabib Benlhabib; John I Baker; Daniel E Keyler; Ashok K Singh
Journal:  J Med Food       Date:  2004       Impact factor: 2.786

8.  A standardized kudzu extract (NPI-031) reduces alcohol consumption in nontreatment-seeking male heavy drinkers.

Authors:  Scott E Lukas; David Penetar; Zhaohui Su; Thomas Geaghan; Melissa Maywalt; Michael Tracy; John Rodolico; Christopher Palmer; Zhongze Ma; David Y-W Lee
Journal:  Psychopharmacology (Berl)       Date:  2012-10-16       Impact factor: 4.530

Review 9.  Anti-dipsotropic isoflavones: the potential therapeutic agents for alcohol dependence.

Authors:  Wing Ming Keung
Journal:  Med Res Rev       Date:  2003-11       Impact factor: 12.944

10.  Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives.

Authors:  D H Overstreet; Y W Lee; A H Rezvani; Y H Pei; H E Criswell; D S Janowsky
Journal:  Alcohol Clin Exp Res       Date:  1996-04       Impact factor: 3.455

View more
  16 in total

1.  Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.

Authors:  Shuping Shuai; Shanlan Yue; Qingting Huang; Wei Wang; Junyi Yang; Ke Lan; Liming Ye
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-11       Impact factor: 2.441

Review 2.  Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.

Authors:  Jing Liang; Richard W Olsen
Journal:  Acta Pharmacol Sin       Date:  2014-08       Impact factor: 6.150

3.  A single dose of kudzu extract reduces alcohol consumption in a binge drinking paradigm.

Authors:  David M Penetar; Lindsay H Toto; David Y-W Lee; Scott E Lukas
Journal:  Drug Alcohol Depend       Date:  2015-05-27       Impact factor: 4.492

4.  Assessment of the Effects of 6 Standard Rodent Diets on Binge-Like and Voluntary Ethanol Consumption in Male C57BL/6J Mice.

Authors:  Simon Alex Marshall; Jennifer A Rinker; Langston K Harrison; Craig A Fletcher; Tina M Herfel; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-25       Impact factor: 3.455

Review 5.  Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks?

Authors:  Carolina L Haass-Koffler; Fatemeh Akhlaghi; Robert M Swift; Lorenzo Leggio
Journal:  J Psychopharmacol       Date:  2017-01-16       Impact factor: 4.153

Review 6.  Pharmacotherapy for alcohol use disorder: current and emerging therapies.

Authors:  Robert M Swift; Elizabeth R Aston
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

7.  Development of Kudzu (Pueraria Montana var. lobata) Reference Materials for the Determination of Isoflavones and Toxic Elements.

Authors:  J Andreas Lippert; Catherine A Rimmer; Melissa M Phillips; Michael A Nelson; Charles A Barber; Laura J Wood; Stephen E Long; Colleen E Bryan; Katherine E Sharpless; James Yen; Adam J Kuszak; Stephen A Wise
Journal:  J AOAC Int       Date:  2022-06-29       Impact factor: 2.028

8.  hVMAT2: A Target of Individualized Medication for Parkinson's Disease.

Authors:  Nian Xiong; Nuomin Li; Eden Martin; Jinlong Yu; Jie Li; Jing Liu; David Yue-Wei Lee; Ole Isacson; Jeffery Vance; Hong Qing; Tao Wang; Zhicheng Lin
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

9.  Puerarin inhibits proliferation and induces apoptosis in human glioblastoma cell lines.

Authors:  Ji-An Yang; Ji-Qiang Li; Ling-Min Shao; Qian Yang; Bao-Hui Liu; Ting-Feng Wu; Peng Wu; Wei Yi; Qian-Xue Chen
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 10.  Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency.

Authors:  Rachel A Montel; Carlos Munoz-Zuluaga; Katie M Stiles; Ronald G Crystal
Journal:  Cancer Gene Ther       Date:  2021-11-19       Impact factor: 5.854

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.